美国Curis  
Curis公司是一家药物开发公司，致力于利用其创新的信号转导通路的药物技术，以寻求建立新的有针对性的治疗癌症的小分子候选药物。 Curis公司根据以往的经验是建立在针对信号通路，包括在Hedgehog信号通路，在其努力开发专有的有针对性的癌症研究项目。

Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. Curis is building upon its previous experiences in targeting signaling pathways, including in the Hedgehog pathway, in its effort to develop proprietary targeted cancer programs.